BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 35182998)

  • 1. Fucosylation of anti-dsDNA IgG1 correlates with disease activity of treatment-naïve systemic lupus erythematosus patients.
    Han J; Zhou Z; Zhang R; You Y; Guo Z; Huang J; Wang F; Sun Y; Liu H; Cheng X; Su Y; Shi H; Hu Q; Teng J; Yang C; Ren S; Ye J
    EBioMedicine; 2022 Mar; 77():103883. PubMed ID: 35182998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distribution of IgG subclass anti-nuclear antibodies (ANAs) in systemic lupus erythematosus.
    Zeng Y; Zhang Y; Chen Q; Huang Q; Lin Y; Wang X; Wang JJ; Jiang L; Xiao Y
    Lupus; 2021 May; 30(6):901-912. PubMed ID: 33622075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IgG subclass distribution of autoantibodies differs between renal and extra-renal relapses in patients with systemic lupus erythematosus.
    Bijl M; Dijstelbloem HM; Oost WW; Bootsma H; Derksen RH; Aten J; Limburg PC; Kallenberg CG
    Rheumatology (Oxford); 2002 Jan; 41(1):62-7. PubMed ID: 11792881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-DFS70 antibodies in systemic lupus erythematosus: Prevalence in a large Chinese cohort and an unexpected association with anti-dsDNA antibodies by a long-term follow-up.
    Dai Y; Li E; Chen D; Niu X; Wang Z; Lu L; Zheng B
    Front Immunol; 2022; 13():913714. PubMed ID: 36189276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-dsDNA and Antichromatin Antibody Isotypes in Serologically Active Clinically Quiescent Systemic Lupus Erythematosus.
    Steiman AJ; Urowitz MB; Ibañez D; Li TT; Gladman DD; Wither J
    J Rheumatol; 2015 May; 42(5):810-6. PubMed ID: 25729033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative analysis of contemporary anti-double stranded DNA antibody assays for systemic lupus erythematosus.
    Bauer CJ; Karakostas P; Weber N; Behning C; Stoffel-Wagner B; Brossart P; Dolscheid-Pommerich R; Schäfer VS
    Front Immunol; 2023; 14():1305865. PubMed ID: 38130723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of a high-avidity IgG ANAs for the diagnosis and activity prediction of systemic lupus erythematosus.
    Zeng Y; Lin Y; Wang X; Zhang Y; Peng F; Wang J; Jiang L; Liang S; Xiao Y
    Clin Rheumatol; 2020 Sep; 39(9):2619-2629. PubMed ID: 32189150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of anti-nucleosome antibody (ANuA) isotypes for the diagnosis and prediction of systemic lupus erythematosus and lupus nephritis activity.
    Zeng Y; Xiao Y; Zeng F; Jiang L; Yan S; Wang X; Lin Q; Yu L; Lu X; Zhang Y; Lin Y
    Clin Exp Med; 2023 Sep; 23(5):1677-1689. PubMed ID: 36385418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-dsDNA titre in female systemic lupus erythematosus patients: relation to disease manifestations, damage and antiphospholipid antibodies.
    Gheita TA; Abaza NM; Hammam N; Mohamed AAA; El-Gazzar II; Eissa AH
    Lupus; 2018 Jun; 27(7):1081-1087. PubMed ID: 29460701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutrophil Extracellular Trap Mitochondrial DNA and Its Autoantibody in Systemic Lupus Erythematosus and a Proof-of-Concept Trial of Metformin.
    Wang H; Li T; Chen S; Gu Y; Ye S
    Arthritis Rheumatol; 2015 Dec; 67(12):3190-200. PubMed ID: 26245802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Constant isotype pattern of anti-dsDNA antibodies in patients with systemic lupus erythematosus.
    Winkler TH; Henschel TA; Kalies I; Baenkler HW; Skvaril F; Kalden JR
    Clin Exp Immunol; 1988 Jun; 72(3):434-9. PubMed ID: 3262461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoantibodies' titre modulation by anti-BlyS treatment in systemic lupus erythematosus.
    Cavazzana I; Kumar R; Pozzari C; Ottaviani R; Fredi M; Piantoni S; Andreoli L; Tincani A; Franceschini F
    Lupus; 2019 Aug; 28(9):1074-1081. PubMed ID: 31296140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Performance of anti-C1q, antinucleosome, and anti-dsDNA antibodies for detecting concurrent disease activity of systemic lupus erythematosus.
    Mok CC; Ho LY; Leung HW; Wong LG
    Transl Res; 2010 Dec; 156(6):320-5. PubMed ID: 21078493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoantibodies to decondensed sperm nuclear deoxyribonucleic acid in patients with antisperm antibodies and systemic lupus erythematosus detected by immunofluorescence flow cytometry.
    D'Cruz OJ; Haas GG; Reichlin M
    Fertil Steril; 1994 Oct; 62(4):834-44. PubMed ID: 7926096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective adsorption of antiphospholipid and anti-dsDNA autoantibodies on histidine based pseudobioaffinity adsorbent from sera of patients with systemic lupus erythematosus (SLE).
    Zeinab M; Hiam KM; Edmond C; Assem E
    J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Jan; 975():77-83. PubMed ID: 25438246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-nucleosome antibodies as a disease marker in systemic lupus erythematosus and its correlation with disease activity and other autoantibodies.
    Pradhan VD; Patwardhan MM; Ghosh K
    Indian J Dermatol Venereol Leprol; 2010; 76(2):145-9. PubMed ID: 20228543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. International multi-center evaluation of a novel chemiluminescence assay for the detection of anti-dsDNA antibodies.
    Bentow C; Lakos G; Martis P; Wahl E; Garcia M; Viñas O; Espinosa G; Cervera R; Sjöwall C; Carmona-Fernandes D; Santos MJ; Hanly JG; Mahler M
    Lupus; 2016 Jul; 25(8):864-72. PubMed ID: 27252263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of IgG subclass autoantibodies in patients with systemic lupus erythematosus and subacute cutaneous lupus erythematosus.
    Elenitsas R; Abell E; Lee YY; Huang J; Deng JS
    J Dermatol Sci; 1990 May; 1(3):207-15. PubMed ID: 2085508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The predictive value of fluctuations in IgM and IgG class anti-dsDNA antibodies for relapses in systemic lupus erythematosus. A prospective long-term observation.
    Bootsma H; Spronk PE; Ter Borg EJ; Hummel EJ; de Boer G; Limburg PC; Kallenberg CG
    Ann Rheum Dis; 1997 Nov; 56(11):661-6. PubMed ID: 9462168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-dsDNA, anti-nucleosome, anti-C1q, and anti-histone antibodies as markers of active lupus nephritis and systemic lupus erythematosus disease activity.
    Shang X; Ren L; Sun G; Yu T; Yao Y; Wang L; Liu F; Zhang L; He X; Liu M
    Immun Inflamm Dis; 2021 Jun; 9(2):407-418. PubMed ID: 33470559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.